🔴 Firefly Neuroscience is trading 5.56% down in pre-market, with no confirmed catalyst identified

Firefly Neuroscience is trading at $1.02 (-5.56%), with no confirmed company-specific catalyst identified for the August 28, 2026 pre-market decline.

• The latest notable release was the August 5 report of a 291% increase in TMS-center customer brain-scan volumes.
• The Nasdaq Composite is down 0.10%, insufficient to establish a market-wide catalyst.
• The move may reflect limited-liquidity trading.